Background-Previous studies indicate that the endothelin system is involved in hypertension, heart failure, atherosclerosis, chronic kidney disease, and diabetes. To explore the potential genetic effects of copy number variations (CNVs) on the endothelin system, which underlie these diseases, we studied the association of genome-wide CNVs with gene expression levels of 7 genes involved in the endothelin system using independent HapMap subjects including 90 Asians (45 Han Chinese and 45 Japanese), 60 whites, and 60 blacks. Methods and Results-For each subject, the genome-wide variations were measured using the Affymetrix 6.0 chip that includes measurements of 906 000 single-nucleotide polymorphisms and 946 000 CNV probes. The gene expression profiles of the transformed B lymphocytes were measured for the same subjects. Among the 210 subjects, we identified 1529 CNV regions on 22 autosomes. By testing the association between CNVs and the gene expression levels in each racial group using linear regression, we identified 4 statistically significant CNV associations in all 3 groups (␣ϭ0.05).
A copy number variation (CNV) is a segment of DNA that is present at a variable number of copies compared with a reference genome sequence. 1 Initial studies by Redon et al 2 used genome-wide single nucleotide polymorphism (SNP) arrays to identify genome-wide CNVs using the HapMap population and identified 1447 CNVs, covering 12% of the human genome. Recently, Stranger et al 3 have demonstrated potentially functional associations between CNV regions and quantitative gene expression levels. CNVs represent a unique opportunity to expand genome-wide association (GWA) studies because they quantitate both the gene dosage and the functional implications of SNP variation. Furthermore, CNVs have been reported to be associated with numerous human disorders such as Parkinson disease, 4 schizophrenia, [5] [6] [7] autism, 8, 9 and Crohn disease. 10 
Clinical Perspective on p 488
Although a number of GWA studies to date have identified SNP loci associated with cardiovascular disease (CVD), [11] [12] [13] the association between CNVs and CVD has not been investigated widely and is less understood. CNVs are suggested to affect CVD and its clinical phenotypes. 14 One approach to assess the role of CNVs in CVD susceptibility is to focus on candidate genes. Endothelin-1 (EDN1) is a well-studied candidate gene for CVD. EDN1 was firstly isolated and cloned as a novel vasoconstrictor in 1988. 15 Human EDN1 is located on chromosome 6 and encodes a 21-amino acid peptide. Besides vasoconstriction, EDN1 also contributes to the vasodilation, oxidative stress, inflammation, and fibrogenic processes through the endothelin system. 16 EDN1 is believed to be an important molecule contributing to the pathogenesis of hypertension, heart failure, atherosclerosis, chronic kidney disease, and diabetes. 16 Importantly, several SNPs in the endothelin system genes have been shown to have functional relevance and association with cardiovascular phenotypes and/or diseases. 17 In this study, we used available data from HapMap subjects to estimate CNV associations with gene expression levels of 7 endothelin system genes, including EDN1, endothelin-2 (EDN2), endothelin-3 (EDN3), endothelin converting enzyme 1 (ECE1), endothelin converting enzyme 2 (ECE2), endothelin receptor type A (EDNRA), and endothelin receptor type B (EDNRB) in 3 racial groups (Asians, whites, and blacks). The goal of the study was to identify associations between CNVs and gene expression levels that were consistent across the 3 racial groups.
Methods

Sample and Data
Two hundred and seventy subjects in 3 racial groups were available from the HapMap project for this study. All 270 subjects were used to identify the specific CNV regions (described later). We used the 210 unrelated HapMap subjects from 3 racial groups to examine the association between CNVs and the expression level of genes in the endothelin system. There were 60 unrelated subjects from Utah; these individuals represent the US white population with Northern and Western European ancestry (parents in 30 trios). There were 60 unrelated subjects collected from the Yoruba people in Nigeria (parents in the 30 trios). Forty-five unrelated Han Chinese in Beijing, China, and 45 unrelated Japanese in Tokyo, Japan, were collected for the Asian group. All subjects gave specific consent for their inclusion in the HapMap project. 18 The mRNA gene expression data for the HapMap samples were obtained from Wellcome Trust Sanger Institute. Gene expression profiles of the 7 endothelin system genes, EDN1, EDN2, EDN3, ECE1, ECE2, EDNRA, and EDNRA, were identified using their unique mRNA RefSeq identifiers from the microarray annotation file. The quantification and normalization of the gene expression data were described in a previous report. 3 The genotyping data for the 270 HapMap subjects were produced and distributed by Affymetrix using the Genome-Wide Human SNP Array 6.0 platform. The CNV genotype data for the 210 HapMap subjects were merged with their gene expression data using the anonymous, unique identifiers. Before CNV analysis, the Contract QC (CQC) value was calculated for each chip (Affymetrix 6.0) for each of the 270 HapMap subjects using Affymetrix Genotyping Console. All of the studied chips passed the CQC threshold of 0.4, which is recommended by Affymetrix for controlling genotyping quality.
Copy Number Variation Analysis
Two different approaches were applied to identify CNV. For the first approach, the copy number analysis module in HelixTree was used to process the Affymetrix raw intensity files (.CEL) and generated a common reference genome with a normal number of copies, using all 270 HapMap subjects. Then the log 2 ratio was calculated for each probe (both SNP probes and copy number probes) on each microarray compared with the reference genome. HelixTree implements a dynamic programming based algorithm, 19, 20 which exhaustively searches through all possible cutpoint positions to find an optimal segmentation of the log 2 ratios for each measured subject. A multivariate method implemented in HelixTree segments log 2 ratios across all subjects simultaneously, finding general copy number regions that may be similar across all subjects (HelixTree manual of copy number analysis module). For a given subject, the mean of the log 2 ratios within each segment for that subject are used as independent variables to identify the CNV associations with a dependent variable.
The second approach used the Affymetrix Genotyping Console 3.0.1 to generate a reference genome for comparing copy numbers and was generated using all 270 raw intensity files (.CEL files) from the human SNP 6.0 array (Affymetrix Genotyping Console 3.0.1 User Manual). Using the common reference genome for comparisons, the intensity ratio of each probe (both SNP probe and copy number probe) on each array was calculated. The boundaries of the common CNV segments were determined using the predefined CNV regions. 21 A hidden Markov model was used to call the copy number state (ie, the number of DNA copies, 2 for a diploid genome like human) for each identified CNV. Genotype calls for the common CNVs (observed in multiple unrelated subjects) were determined using the Canary algorithms. 21 The chromosomal boundaries and the copy number state were exported and used in the association analysis of gene expression levels.
Statistical Analysis
Population genetic parameters for CNVs (copy number states) were calculated, including minor allele frequencies (MAFs), genotype frequencies, and a 2 test for departures from expectations under Hardy-Weinberg equilibrium for the 210 unrelated subjects in 3 racial groups. Summary statistics for CNVs and linear regression models were generated using the statistical software R. Single CNV associations with gene expression levels were evaluated in each racial group separately using standard linear regression models. For CNV associations with P value Ͻ0.05 in all 3 racial groups, we pooled the 210 HapMap subjects from all racial groups after testing for heterogeneity (described later) and performed the CNV association analysis. To estimate the relationship between the associated CNVs and SNPs, we tested the additive effect of SNPs associated with gene expression levels in the pooled sample.
For the CNV and SNP association tests conducted on the pooled sample of 3 racial groups, and on the sample of each of the 3 racial groups, we used the principal component (PC) analysis to adjust for the population stratification. 22 The top 10 PCs of the 752 286 autosomal SNPs (MAF Ͼ0.05 and call rate Ͼ95%) were calculated within each race and in the pooled sample. The PCs significantly associated with the gene expression levels were used as covariates in the multiple regression model of testing CNV associations. In the CNV association analysis of EDN1 gene expression within each racial group, none of top 10 PCs is significantly associated with the outcome and no PC was used to adjust the linear regression model within each racial group.
All regression analyses were performed with the mean log 2 ratio of each CNV fragment as the independent variable. The null hypothesis of no CNV effect was evaluated by testing whether the regression coefficients were significantly different from zero. The CNV genotypes (copy number states exported from Affymetrix Genotyping Console 3.0.1 using Canary) were also used as independent variables in regression analysis to confirm the findings. In the CNV genotype test, we assumed an additive model of the DNA copy number effect for each CNV. All tests were 2-sided and the ␣ level was set to 0.05.
For those CNVs that were significant in 3 racial groups, we applied 2 methods, Cochran Q test 23 A total of 906 602 SNPs were genotyped using the Affymetrix Genome-Wide Human SNP Array 6.0 platform. SNPs were excluded if they had unknown chromosomal location, a call rate Ͻ95% or a MAF Ͻ0.05. These quality control filters resulted in 752 286 SNPs available for analysis in 210 independent HapMap subjects. The additive effect of each SNP was estimated by using a linear regression model.
Results
Among the 270 HapMap genotyped subjects, we identified 1529 CNV regions on 22 autosomes using copy number analysis module implemented in HelixTree 6.2 software package. We identified statistically significant associations between 4 CNVs and gene expression levels among the endothelin system in each of the 3 racial groups. One CNV region (chromosome 6, 79 025 772 bp to 79 091 892 bp) was associated with EDN1 expression, one CNV region (chromo-
We focused on the CNV-EDN1 associations, as they represented the most statistically significant findings in this study. The CNV-EDN1 associations are summarized in Table 1 . The numbers of CNV regions demonstrating statistically significant associations with EDN1 expression were 77 in Asians, 218 in whites, and 106 in blacks. We repeated the CNV association analysis of EDN1 gene expression using the standardized copy number states called by Affymetrix Genotyping Console 3.0.1. Both methods identified the CNV region (CNV_6q14.1) on chromosome 6 with identical boundaries. The P values are higher when using the discrete CNV states in the linear regression model than those when using the continuous log 2 ratio. The P values, however, remain statistically significant within each racial group (Table 1). Pooling the samples from the 3 racial groups together yielded highly significant P values for the log 2 ratio test and the copy number test with adjustment of population stratification using PC analysis. 22 Among the top 10 PCs, the first and second were associated with EDN1 gene expression. In the pooled CNV association test of EDN1 expression, we used these 2 PCs to adjust for population stratification. The P values of CNV_6q14.1 in the multiple regression models were 4.34ϫ10 Ϫ6 (log 2 ratio test) and 1.15ϫ10 Ϫ5 (copy number test). These P values were significant after Bonferroni correction for multiple testing, with adjusted P values of 4.77ϫ10 Ϫ3 (log 2 ratio test) and 1.27ϫ10 Ϫ2 (copy number test). The results are similar when including the top 10 PCs in the adjustment model (nominal P values are 1.07ϫ10 Ϫ5 for log 2 ratio test and 2.66ϫ10
Ϫ5 for copy number test). The proportion of variance (R 2 ) explained by this CNV ranges from 0.071 in the Asians to 0.142 in the blacks (log 2 ratio test) and from 0.058 in the Asians to 0.121 in the blacks (copy number test). The R 2 values from the copy number test are slightly smaller than those obtained when using the mean log 2 ratio as the independent variable. The R 2 values between the 2 pooled tests (mean log 2 ratio versus CNV state) are comparable (0.146 versus 0.143). Previous studies found that R 2 values or P values generated in the association test using the log 2 ratios or the CNV genotypes are strongly correlated (Pearson correlation coefficients Ͼ0.9), indicating that log 2 ratios can be used directly. 3 In our study, we also found that the linear relationship between CNV_6q14.1 and EDN1 expression is very similar using either log 2 ratio or CNV genotype (Figure) , and the R 2 values or P values from the linear regression model are also consistent (Table 1) .
In addition, we examined the heterogeneity of the estimated betas of the CNV_6q14.1 association with EDN1 gene expression levels in 3 racial groups, using Cochran Q test 23 and Higgins's inconsistency test. 24 The P value of the Cochran Q test was 0.649 and the I 2 value was 4.6% in the inconsistency test (possible range 0% to 100%, I 2 Ͻ25% indicates low heterogeneity). 24 Both tests indicate that no heterogeneity was observed across the CNV_6q14.1-EDN1 association results from 3 racial groups. The beta coefficients for CNV associations are all of the same relative magnitude and direction of association (eg, 0.381 [Asian], 0.427 [white], and 0.609 [black] for the CNV genotype association). We recognize, however, that we may have low power to detect heterogeneity with only 3 groups. Table 2 summarizes the population genetics of this EDN1 associated CNV. The minor allele (ie, deletion allele) frequency in whites is 0.242, which is much higher than that in Asian (MAFϭ0.061) and black (MAFϭ0.075) populations. None of the 3 populations have significant P values from the 2 test of Hardy-Weinberg equilibrium, with an alpha level of 0.05 (Table 2 ). The EDN1 associated CNV spans 66 kbp on 6q14.1 starting at 79 025 772 bp and ending at 79 091 892 bp (NCBI build 36). This CNV has been previously identified and repeatedly reported in several human CNV studies. 2, 25, 26 The GWA of 752 277 autosomal SNPs (MAF Ͼ5% and call rate Ͼ95%) with EDN1 gene expression level was conducted using all 210 unrelated HapMap subjects with adjustment for population stratification by PC analysis 22 .The lowest P value among 752 277 SNP tests for the pooled sample is 1.06ϫ10 Ϫ6 , which is not significant after adjusting for multiple testing (Bonferoni corrected P value is 0.79). Within the flanking region of CNV_6q14.1 (25 kb upstream and downstream), there are 13 SNPs (5 upstream and 8 downstream) genotyped on the Affymetrix 6.0 array with a MAF Ͼ5% and call rate Ͼ95%. Their distances and linkage disequilibrium correlations to CNV_6q14.1, and the associations with EDN1 gene expression levels are summarized in supplemental Table 1 . The lowest P value among 13 SNPs is 0.006 (rs818269). None of these neighboring SNPs have strong linkage disequilibrium with CNV_6q14.1. 
Discussion
CNVs have been suggested to influence CVD because of their potential biological effects on various CVD candidate genes. 14 One plausible mechanism is indicated by the effect of CNV on the gene expression levels of given disease candidate genes. 10 Using unrelated Asians, whites, and blacks from HapMap samples, we investigated the associations between genome-wide CNVs with the gene expression levels of the endothelin system, which includes well-studied candidate genes for hypertension, atherosclerosis, heart failure, chronic kidney disease, and diabetes. In this study, a known deletion variation on chromosome 6 was significantly associated with EDN1 expression in each of the 3 racial groups considered.
Although there is no known gene overlapped with the identified CNV region on chromosome 6, 4 genes are located within 1 Mbp window from the CNV region, including 5-hydroxytryptamine (serotonin) receptor 1B (HTR1B, 796 Kbp upstream), interleukin-1 receptor-associated kinase 1 binding protein 1 (IRAK1BP1, 608 Kbp downstream), pleckstrin homology domain interacting protein (PHIP, 684 Kbp downstream), and high-mobility group nucleosomal binding domain 3 (HMGN3, 942 Kb downstream). Two neighboring blocks within the chromosome 6 CNV, 79033035 bp to 79033306 bp and 79033329 bp to 79033429 bp, are highly conserved among 10 mammalian species (UCSC genome browser). The log-odds score for the 2 blocks are 644 and 272 correspondingly computed by PhastCons, 27 which is a program for identifying evolutionarily conserved elements in a multiple alignment, given a phylogenetic tree. The log-odds scores range from 0 to 1000 and the higher score indicates more conserved region across species. On the other hand, Ϸ60% of conserved bases in the ENCODE regions are assigned at least 1 molecular function. 28 The interspecies conservation within the chromosome 6 CNV region suggests plausible biological functions.
Three other CNVs were also associated with gene expression levels of EDN3, ECE1, and EDNRA. Taken together, these associations demonstrate a possible impact of CNVs on CVD, chronic kidney disease, and diabetes through the endothelin system, although further epidemiological studies are needed to confirm the potential relationships between the CNVs and these complex common diseases.
In this study, the gene expression profile was measured in transformed B lymphocytes. Therefore, the CNV association For CNV analysis, data quality needs to be carefully controlled to guard against false CNV calls. In Affymetrix Genotyping Console, the CQC value was calculated for each chip (Affymetrix 6.0) for each of the 270 HapMap subjects. The CQC values of the chips from the 210 unrelated HapMap subjects range from 1.0 to 3.7 with a mean of 2.6. All of the chips passed the CQC threshold of 0.4, which is recommended by Affymetrix for controlling genotyping quality. These high-quality chip results were used in the CNV analysis.
CNV association studies show promise as a complement to the current GWA studies using SNPs to identify disease loci on the human genome. 10 Because the CNVs have large base-pair coverage on the human genome, 2 their functional roles in human disease development are substantial. At least one thousand human CNVs have been characterized and validated in recent years 2,25,29 and more will be discovered with improved technology. 30 Unlike the SNPs, CNVs tend to have differential boundaries across individuals. 30 This property of CNV limits the current population studies with the more conserved CNVs with common boundaries among individuals. The advancement of technology in both CNV measurements and CNV calling algorithms 21 will improve our understanding of the boundaries, origins, and distributions of human CNVs, as well as our knowledge of their functional roles in human diseases. The ongoing GWA studies provide a unique opportunity to study the genomewide CNV association with CVD and other common human diseases. Along with the genome-wide SNP data, the genome-wide CNV data will help us to better understand the genetic architecture of common diseases.
